Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?

Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing ins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International health 2024-05, Vol.16 (5), p.568-570
1. Verfasser: Awosusi, Abiodun E
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 570
container_issue 5
container_start_page 568
container_title International health
container_volume 16
creator Awosusi, Abiodun E
description Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.
doi_str_mv 10.1093/inthealth/ihae032
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11375562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/inthealth/ihae032</oup_id><sourcerecordid>3051940455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</originalsourceid><addsrcrecordid>eNqNkTFPwzAQhS0EoqXwA1hQRgZC7ThO4qmqKqCVQCzAal0vTmOUOMVOkPj3pGqJYGOy5ffuu_M9Qi4ZvWVU8qmxbamhasupKUFTHh2RMcvSJOQxFcfDnfEROfP-ndIk40l0SkY8S1kkkmxMlisf9JBgXjiDYIM3QDRWB09guwKw7Zyxm2COqCvtoG1cAEGusem21U6oNZZgja9n5-SkgMrri8M5Ia_3dy-LZfj4_LBazB9D5Ey2YVRQIVEAlxhHBYc8yWlMkfWPxTpDEaUUQcs1T1DyiHNBNcqYFTnmqcwyxidktuduu3Wtc9S2dVCprTM1uC_VgFF_FWtKtWk-FWM8FSKJesL1geCaj077VtXG9_-rwOqm84pTwWRMYyF6K9tb0TXeO10MfRhVuwjUEIE6RNDXXP0ecKj42XlvuNkb-iX-g_cNAmyWZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051940455</pqid></control><display><type>article</type><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Awosusi, Abiodun E</creator><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><description>Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</description><identifier>ISSN: 1876-3413</identifier><identifier>ISSN: 1876-3405</identifier><identifier>EISSN: 1876-3405</identifier><identifier>DOI: 10.1093/inthealth/ihae032</identifier><identifier>PMID: 38712568</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><ispartof>International health, 2024-05, Vol.16 (5), p.568-570</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1598,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38712568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><title>International health</title><addtitle>Int Health</addtitle><description>Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</description><issn>1876-3413</issn><issn>1876-3405</issn><issn>1876-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqNkTFPwzAQhS0EoqXwA1hQRgZC7ThO4qmqKqCVQCzAal0vTmOUOMVOkPj3pGqJYGOy5ffuu_M9Qi4ZvWVU8qmxbamhasupKUFTHh2RMcvSJOQxFcfDnfEROfP-ndIk40l0SkY8S1kkkmxMlisf9JBgXjiDYIM3QDRWB09guwKw7Zyxm2COqCvtoG1cAEGusem21U6oNZZgja9n5-SkgMrri8M5Ia_3dy-LZfj4_LBazB9D5Ey2YVRQIVEAlxhHBYc8yWlMkfWPxTpDEaUUQcs1T1DyiHNBNcqYFTnmqcwyxidktuduu3Wtc9S2dVCprTM1uC_VgFF_FWtKtWk-FWM8FSKJesL1geCaj077VtXG9_-rwOqm84pTwWRMYyF6K9tb0TXeO10MfRhVuwjUEIE6RNDXXP0ecKj42XlvuNkb-iX-g_cNAmyWZA</recordid><startdate>20240507</startdate><enddate>20240507</enddate><creator>Awosusi, Abiodun E</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240507</creationdate><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><author>Awosusi, Abiodun E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awosusi, Abiodun E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</atitle><jtitle>International health</jtitle><addtitle>Int Health</addtitle><date>2024-05-07</date><risdate>2024</risdate><volume>16</volume><issue>5</issue><spage>568</spage><epage>570</epage><pages>568-570</pages><issn>1876-3413</issn><issn>1876-3405</issn><eissn>1876-3405</eissn><abstract>Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>38712568</pmid><doi>10.1093/inthealth/ihae032</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1876-3413
ispartof International health, 2024-05, Vol.16 (5), p.568-570
issn 1876-3413
1876-3405
1876-3405
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11375562
source Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals
title Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A07%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20African%20Vaccine%20Manufacturing%20Accelerator%20a%20decoupling%20mechanism?&rft.jtitle=International%20health&rft.au=Awosusi,%20Abiodun%20E&rft.date=2024-05-07&rft.volume=16&rft.issue=5&rft.spage=568&rft.epage=570&rft.pages=568-570&rft.issn=1876-3413&rft.eissn=1876-3405&rft_id=info:doi/10.1093/inthealth/ihae032&rft_dat=%3Cproquest_pubme%3E3051940455%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3051940455&rft_id=info:pmid/38712568&rft_oup_id=10.1093/inthealth/ihae032&rfr_iscdi=true